27.09.2024
В. А. Белоглазов; Л. Ш. Дудченко; Р. Х. Усеинова; И. А. Яцков; Е. А. Соловьева; Г. Н. Андреева
of symptoms in patients who have had COVID-19 and the role of systemic inflammation and endotoxemia markers
03.10.2023
Е. А. Бородулина; Ж. П. Васнева; Е. С. Вдоушкина; Б. Е. Бородулин; Л. В. Поваляева
in patients with lung damage up to 30 % in COVID-19.
Material and methods. 73 people were examined during
10.12.2022
Т. В. Гома; А. Н. Калягин; О. В. Рыжкова; Н. С. Соловьева
in COVID-19. Using olokizumab which inhibits IL-6 production in treatment of COVID-19 is pathogenetically
08.04.2021
Е. А. Бородулина; Ж. П. Васнева; Е. С. Вдоушкина; Б. Е. Бородулин; Л. В. Поваляева
Against the background of priority attention paid to the COVID-19 pandemic, there are also cases
